Javelin Pharmaceuticals Inc. is an AMEX listed security that has been trading in a range between $2.66 and $7.60 over the past year. With 47,892,610 shares outstanding, a recent price of $5.77 gives a total market capitalization of $276,340,359. While there are certainly larger companies, Javelin Pharmaceuticals Inc. has definitely earned its place in the pack. Last year, Javelin Pharmaceuticals Inc. created $-0.54 in earnings for every share outstanding.
Javelin Pharmaceuticals Inc. is currently priced by the market at 0.00 times last year’s earnings. Many trading multiples around the world are quite attractive these days, but don’t be fooled. A Price to Earnings ratio of 0 simply means that the security didn’t make any money last year.
With a share price under $50 a share and earnings per share below $1 a share, Javelin Pharmaceuticals Inc. is unlikely to be an interesting value proposition.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment